Vendor review
Nantong Guangyuan Chemical GYC reviews
Nantong Guangyuan Chemical GYC reviews from 54 independent lab tests (Tirzepatide, Retatrutide and Cagrilintide): grade A, purity and fill accuracy. Is Nantong Guangyuan Chemical GYC legit? See what its vials showed.
What the lab tests show
54 tests on record, newest first. Scores are purity divided by ten.
| Date | Product | Purity | Quantity | Identity | Certificate |
|---|---|---|---|---|---|
| Oct 14, 2026 | Tirzepatide | 99.99 % | 64.46 mg of 60 mg (7 %) | Pass | View |
| Oct 14, 2026 | Retatrutide | 99.99 % | 54.28 mg of 50 mg (9 %) | Pass | View |
| Oct 6, 2026 | Retatrutide | 100 % | 19.107 mg of 15 mg (27 %) | Pass | View |
| Oct 1, 2026 | Tirzepatide | 99.9 % | 59.99 mg of 60 mg (0 %) | Pass | View |
| Sep 30, 2026 | Retatrutide | 99.9 % | 19.99 mg of 20 mg (0 %) | Pass | View |
| Jul 17, 2026 | Cagrilintide | 99.9 % | 11.8 mg of 10 mg (18 %) | Pass | View |
| Jul 13, 2026 | Retatrutide | 99.9 % | 57.2 mg of 60 mg (-5 %) | Pass | View |
| Mar 25, 2026 | Tirzepatide | 99.9 % | 64.6 mg of 60 mg (8 %) | Pass | View |
| Mar 18, 2026 | Retatrutide | 99.9 % | 46.7 mg of 50 mg (-7 %) | Pass | View |
| Mar 3, 2026 | Retatrutide | 99.9 % | 11.1 mg of 10 mg (11 %) | Pass | View |
| Mar 3, 2026 | Tirzepatide | 99.6 % | 10.9 mg of 10 mg (9 %) | Pass | View |
| Mar 1, 2026 | Tirzepatide | 99.8 % | 29.1 mg of 30 mg (-3 %) | Pass | View |
| Feb 26, 2026 | Tirzepatide | 99.02 % | 31 mg of 30 mg (3 %) | Pass | View |
| Feb 16, 2026 | Retatrutide | 99.9 % | 10 mg of 10 mg (0 %) | Pass | View |
| Feb 11, 2026 | Retatrutide | 99.88 % | 66 mg of 60 mg (10 %) | Pass | View |
| Feb 10, 2026 | Tirzepatide | 99.9 % | 60.1 mg of 60 mg (0 %) | Pass | View |
| Feb 4, 2026 | Retatrutide | 99.8 % | 51.2 mg of 50 mg (2 %) | Pass | View |
| Jan 26, 2026 | Tirzepatide | 99.8 % | 11.3 mg of 10 mg (13 %) | Pass | View |
| Jan 26, 2026 | Tirzepatide | 99.8 % | 22.9 mg of 20 mg (15 %) | Pass | View |
| Jan 26, 2026 | Retatrutide | 99.8 % | 10.7 mg of 10 mg (7 %) | Pass | View |
| Jan 26, 2026 | Retatrutide | 99.9 % | 20.3 mg of 20 mg (2 %) | Pass | View |
| Jan 26, 2026 | Retatrutide | 99.7 % | 9.9 mg of 10 mg (-1 %) | Pass | View |
| Jan 26, 2026 | Retatrutide | 99.7 % | 15.2 mg of 15 mg (1 %) | Pass | View |
| Jan 26, 2026 | Retatrutide | 99.9 % | 15.5 mg of 15 mg (3 %) | Pass | View |
| Jan 15, 2026 | Retatrutide | 99.9 % | 21.7 mg of 20 mg (9 %) | Pass | View |
| Jan 15, 2026 | Retatrutide | 99.8 % | 30.4 mg of 30 mg (1 %) | Pass | View |
| Jan 9, 2026 | Tirzepatide | 99.95 % | 37.9 mg of 40 mg (-5 %) | Pass | View |
| Jan 7, 2026 | Tirzepatide | 99.7 % | 9.9 mg of 10 mg (-1 %) | Pass | View |
| Jan 7, 2026 | Tirzepatide | 99.9 % | 57 mg of 50 mg (14 %) | Pass | View |
| Dec 5, 2025 | Semaglutide | 98.5 % | 5.2 mg of 5 mg (4 %) | Pass | View |
| Dec 2, 2025 | Cagrilintide | 99.6 % | 6.7 mg of 5 mg (34 %) | Pass | View |
| Nov 25, 2025 | Tirzepatide | 98.78 % | 41.1 mg of 40 mg (3 %) | Pass | View |
| Nov 23, 2025 | Tirzepatide | 99.869 % | 40.44 mg of 40 mg (1 %) | Pass | View |
| Nov 23, 2025 | Tirzepatide | 99.9 % | 43.7 mg of 50 mg (-13 %) | Pass | View |
| Nov 23, 2025 | Retatrutide | 99.9 % | 33 mg of 30 mg (10 %) | Pass | View |
| Nov 23, 2025 | Semaglutide | 99.9 % | 24.5 mg of 21 mg (17 %) | Pass | View |
| Nov 22, 2025 | Cagrilintide | 99.7 % | 7.17 mg of 5 mg (43 %) | Pass | View |
| Nov 14, 2025 | Cagrilintide | 99.9 % | 13.12 mg of 10 mg (31 %) | Pass | View |
| Nov 4, 2025 | Tirzepatide | 99.95 % | 42.3 mg of 50 mg (-15 %) | Pass | View |
| Nov 4, 2025 | Retatrutide | 99.87 % | 46.7 mg of 50 mg (-7 %) | Pass | View |
| Nov 3, 2025 | Retatrutide | 99.9 % | 30.19 mg of 50 mg (-40 %) | Pass | View |
| Oct 30, 2025 | Tirzepatide | 99.7 % | 64.49 mg of 60 mg (7 %) | Pass | View |
| Oct 30, 2025 | Retatrutide | 99.8 % | 15.8 mg of 15 mg (5 %) | Pass | View |
| Oct 30, 2025 | Semaglutide | 99.2 % | 5.6 mg of 5 mg (12 %) | Pass | View |
| Oct 29, 2025 | Retatrutide | 99.95 % | 14.6 mg of 15 mg (-3 %) | Pass | View |
| Oct 24, 2025 | Tirzepatide | 99.9 % | 35.57 mg of 30 mg (19 %) | Pass | View |
| Oct 24, 2025 | Tirzepatide | 99.9 % | 35.51 mg of 30 mg (18 %) | Pass | View |
| Oct 23, 2025 | Tirzepatide | 99.95 % | 20.1 mg of 20 mg (1 %) | Pass | View |
| Oct 23, 2025 | Tirzepatide | 99.95 % | 25.8 mg of 30 mg (-14 %) | Pass | View |
| Oct 22, 2025 | Tirzepatide | 99.862 % | 44.31 mg of 40 mg (11 %) | Pass | View |
| Oct 22, 2025 | Tirzepatide | 99.998 % | 35.71 mg of 30 mg (19 %) | Pass | View |
| Oct 5, 2025 | Retatrutide | 99.77 % | 46.9 mg of 50 mg (-6 %) | Pass | View |
| Oct 3, 2025 | Tirzepatide | 99.92 % | 33.3 mg of 30 mg (11 %) | Pass | View |
| Oct 3, 2025 | Tirzepatide | 99.74 % | 19.8 mg of 20 mg (-1 %) | Pass | View |
What Nantong Guangyuan Chemical GYC sells
No current listings on record.
About Nantong Guangyuan Chemical GYC
DO NOT purchase from ggpeps.net: evidence of fraud, verify from a trusted source that you are purchasing from the legitimate vendor, and not from a fake site. Community reports of scams with payments being taken but no packages being sent. Beware.